Xenon Pharmaceuticals Inc. (XENE) Financials

XENE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 671.1 million 34.5 million
2023-06-30 684.9 million 38.4 million
2023-03-31 719.9 million 32.9 million
2022-12-31 754.1 million 32.6 million

XENE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -43.4 million 8.7 million
2023-06-30 -35.4 million 8.5 million
2023-03-31 -36.6 million 6.0 million
2022-12-31 -34.5 million 5.8 million

XENE Net Income

No data available :(

XENE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 526.7 million - 11.0 million
2023-06-30 539.6 million - 11.5 million
2023-03-31 527.0 million - 11.6 million
2022-12-31 592.1 million - 10.4 million

XENE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 66.0 million
2023-06-30 65.9 million
2023-03-31 65.7 million
2022-12-31 65.7 million

XENE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1.2 million 42.9 million 12.8 million -
2023-06-30 2.1 million 44.0 million 11.6 million -
2023-03-31 2.2 million 39.5 million 9.5 million -
2022-12-31 1.8 million 34.8 million 8.5 million -

XENE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 8766 -

XENE

Price: $42.49

52 week price:
27.99
50.99

Earnings Per Share: -2.73 USD

P/E Ratio: -18.81

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 730900

Ebitda: -8.5 million

Market Capitalization: 3.2 billion

Links: